Stock Chart

OCUL

$9.14 -8.14%
Score: 50.4 HOLD
LEAPs: HOLD $22
i
LEAPs Option Signal

Type: HOLD wallstreet
Strike: $22
Premium: $1.83
Expiry: Jan 15, 2027
Target: $24
Score: 23

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $5.88 - $9.43 NEUTRAL
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.02
Vol: 1.43x (vs SPY: 1.1x | vs QQQ: 1.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About OCUL - Ocular Therapeutix, Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Key Statistics

Market Cap $2B

This OCUL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track OCUL's price movements with trendlines, gamma walls, and key support/resistance levels.